Daymark Wealth Partners’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Hold |
45,500
| – | – | 0.06% | 200 |
|
|
2025
Q1 | $1.79M | Buy |
45,500
+4,000
| +10% | +$158K | 0.08% | 181 |
|
|
2024
Q4 | $1.25M | Buy |
41,500
+689
| +2% | +$20.7K | 0.05% | 204 |
|
|
2024
Q3 | $955K | Buy |
40,811
+17,311
| +74% | +$405K | 0.04% | 253 |
|
|
2024
Q2 | $418K | Hold |
23,500
| – | – | 0.02% | 347 |
|
|
2024
Q1 | $357K | Buy |
23,500
+10,000
| +74% | +$152K | 0.02% | 314 |
|
|
2023
Q4 | $231K | Hold |
13,500
| – | – | 0.01% | 363 |
|
|
2023
Q3 | $113K | Buy |
+13,500
| New | +$113K | 0.01% | 370 |
|